Concepedia

Paul J. Whiting

PJ

Statistics

Publications

161

Citations

21.2K

H-Index

80

Active since

1983

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University College London

University of Colorado Health

Salk Institute for Biological Studies

Paul J. Whiting is an author at MSD (UK) Limited (United Kingdom) specializing in medicine, neuropharmacology, and neuroscience.

Top concepts

MedicineNeuropharmacologyPharmacologyNeuroscienceSocial SciencesSignal TransductionMolecular PharmacologyPhysiologyCell BiologyNeurochemistry

Publications per year

1983–2023

161

Publications

161

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

Ruth M. McKernan, T.W. Rosahl, David S. Reynolds et al. · Nature Neuroscience · 2000 · 935 citations

Molecular Pharmacology, Psychiatry, Neurophysiology +13

Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration

Lyndon da Cruz, Kate Fynes, Odysseas Georgiadis et al. · Nature Biotechnology · 2018 · 695 citations

Ocular Disease, Developmental Biology, Retina +13

DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling

J. Kirsty Millar, Ben Pickard, Shaun Mackie et al. · Science · 2005 · 648 citations

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA<sub>A</sub>Receptor

Neil Collinson, Frederick M. Kuenzi, Wolfgang Jarolimek et al. · Journal of Neuroscience · 2002 · 618 citations · Full text

Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors

Stuart M. Chambers, Yuchen Qi, Yvonne Mica et al. · Nature Biotechnology · 2012 · 611 citations · Full text

Developmental Timing, Induced Pluripotent Stem Cell, Developmental Biology +10

1–5 of 161